Abstract:During inflammation, human neutrophils engage β 2 -integrins to migrate from the blood circulation to inflammatory sites with high cytokine but low oxygen concentrations. We tested the hypothesis that the inhibition of prolyl hydroxylase domain-containing enzymes (PHDs), cytokines, and β 2 -integrins cooperates in HIF pathway activation in neutrophils. Using either the PHD inhibitor roxadustat (ROX) (pseudohypoxia) or normobaric hypoxia to stabilize HIF, we observed HIF1α protein accumulation in adherent neutrophils. Several inflammatory mediators did not induce HIF1α protein but provided additive or even synergistic signals (e.g., GM-CSF) under pseudohypoxic and hypoxic conditions. Importantly, and in contrast to adherent neutrophils, HIF1α protein expression was not detected in strictly suspended neutrophils despite PHD enzyme inhibition and the presence of inflammatory mediators. Blocking β 2 -integrins in adherent and activating β 2 -integrins in suspension neutrophils established the indispensability of β 2 -integrins for increasing HIF1α protein. Using GM-CSF as an example, increased HIF1α mRNA transcription via JAK2-STAT3 was necessary but not sufficient for HIF1α protein upregulation. Importantly, we found that β 2 -integrins led to HIF1α mRNA translation through the phosphorylation of the essential translation initiation factors eIF4E and 4EBP1. Finally, pseudohypoxic and hypoxic conditions inducing HIF1α consistently delayed apoptosis in adherent neutrophils on fibronectin under low serum concentrations. Pharmacological HIF1α inhibition reversed delayed apoptosis, supporting the importance of this pathway for neutrophil survival under conditions mimicking extravascular sites. We describe a novel β 2 -integrin-controlled mechanism of HIF1α stabilization in human neutrophils. Conceivably, this mechanism restricts HIF1α activation in response to hypoxia and pharmacological PHD enzyme inhibitors to neutrophils migrating toward inflammatory sites.

High Affinity Bent Β2 Integrin Binds Ligand in Cis and Regulates Inflammation

Neutrophil Recruitment Limited by High-Affinity Bent Β2 Integrin Binding Ligand in Cis.

Observing Force-Regulated Conformational Changes And Ligand Dissociation From A Single Integrin On Cells

Observing Real-Time Force-Dependent Conformational Changes Of Single Integrin On Living Cells And Their Regulation Of Ligand Dissociation

High-Affinity Bent Β2-Integrin Molecules in Arresting Neutrophils Face Each Other Through Binding to ICAMs in Cis

Structural basis and kinetics of force-induced conformational changes of an αA domain-containing integrin.

Molecular Dynamics Simulations Of Forced Unbending Of Integrin Alpha(V)Beta(3)

Conformation Coupling Between the I-like Domain Alpha7 Helix and the Hybrid Domain of Beta3 Integrins

Super Resolution Imaging Visualized the Nanoscaled Localization of Integrin Activation During Human Neutrophil Arrest

Kindlin‐3 Organizes a Ring of Clustered High Affinity Β2 Integrins During Human Neutrophil Spreading under Flow

Recruitment of Kindlin‐3 to Plasma Membrane Through Its PH Domain Precedes High Affinity Β2 Integrin Activation and Neutrophil Arrest

Structural basis of integrin regulation and signaling.

Heterodimerization of Integrin Mac-1 Subunits Studied by Single-Molecule Imaging.

Kindlin-3 Recruitment to the Plasma Membrane Precedes High Affinity Β2 Integrin and Neutrophil Arrest from Rolling.

A humanized β2 integrin knockin mouse reveals localized intra- and extravascular neutrophil integrin activation in vivo

Interaction Between Single Molecules of Mac-1 and ICAM-1 in Living Cells: an Atomic Force Microscopy Study.

Detection of Constitutive Heterodimerization of the Integrin Mac-1 Subunits by Fluorescence Resonance Energy Transfer in Living Cells

Frontline Science: A Flexible Kink in the Transmembrane Domain Impairs Β2 Integrin Extension and Cell Arrest from Rolling.

Dynamic Control of Β1 Integrin Adhesion by the Plexind1-Sema3e Axis

Organized spatial patterns of activated β2 integrins in arresting neutrophils

β2-integrins control HIF1α activation in human neutrophils